最新ニュース FingerMotion (NASDAQ:FNGR) 株価情報

FingerMotion

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

FingerMotion Inc

WIIM

Walmart shares are trading higher following Q1 financial results.

News

SBC Medical Group Unveils $5M Share Buyback Plan, Citing Undervalued Stock And Growth Potential

HC Wainwright &amp; Co. analyst Mitchell Kapoor upgrades CytomX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTMX#NASDAQ">CTMX</a>) from Neutral to Buy and maintains the price target from $5 to $5.

Upgrades

Price Target

Analyst Ratings

CTMX

HC Wainwright & Co. Upgrades CytomX Therapeutics to Buy, Maintains Price Target to $5

<figure class="table"> 
<table>
<tbody>
<tr>
<td>-</td>
<td>CLIK will collaborate with Flash Mutual, an advanced technology company under the Tencent SSV initiatives, to jointly promote 24-hour instant device services for senior citizens in Hong Kong</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>-</td>
<td>Tencent SSV is an initiative launched by Tencent, a world leading internet and technology company, aiming to leverage its unique digital platform and technology to drive Sustainable Social Value (SSV) globally</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>-</td>
<td>CLIK also announces the appointment of Mr. Lam Kai Yuen, Gabi as the new independent director</td>
</tr>
</tbody>
</table>
</figure>

Contracts

General

CLIK

Click Holdings Signed A Cooperation Agreement With Flash Mutual Technology In Which Both Parties Agreed To Jointly Promote 24-Hour Instant Device Service For Senior Citizens In Hong Kong

Earnings

Earnings Misses

PYXS

Pyxis Oncology Q1 EPS $(0.35) Misses $(0.29) Estimate

Fonar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FONR#NASDAQ">FONR</a>) reported quarterly earnings of $0.37 per share. This is a 37.04 percent increase over earnings of $0.27 per share from the same period last year. The company reported $27.16 million in sales this quarter. This is a 5.63 percent increase over sales of $25.72 million the same period last year.

FONR

Fonar Q3 EPS $0.37 Up From $0.27 YoY, Sales $27.16M Up From $25.72M YoY

Enbridge Sells 12.5% Stake In Westcoast Gas Pipeline To Indigenous Alliance In C$715M Deal

Needham analyst Scott Berg reiterates Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) with a Buy and maintains $40 price target.

Reiteration

GLBE

Needham Reiterates Buy on Global E Online, Maintains $40 Price Target

Following the issuance of the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnmg.com%2Fupdated-feasibility-study%2F&amp;esheet=54255452&amp;newsitemid=20250515626279&amp;lan=en-US&amp;anchor=NI+43-101+Updated+Technical+Feasibility+Study+Report+for+the+Matawinie+Mine+and+B%26eacute%3Bcancour+Battery+Material+Plant+Integrated+Graphite+Projects&amp;index=1&amp;md5=b166f23d4579e193f536dd82cfc58585">NI 43-101 Updated Technical Feasibility Study Report for the Matawinie Mine and Bécancour Battery Material Plant Integrated Graphite Projects</a> (the "Updated Feasibility Study"), Nouveau Monde Graphite Inc. ("NMG" or the "Company") ((<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;,%20url=https%3A%2F%2Fwww.nyse.com%2Fquote%2FXNYS%3ANMG&amp;,%20esheet=54255452&amp;,%20newsitemid=20250515626279&amp;,%20lan=en-US&amp;,%20anchor=NYSE%3A+NMG&amp;,%20index=2&amp;,%20NYSE:%3Ca%20class=">NMG</a>, <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;,%20url=https%3A%2F%2Fmoney.tmx.com%2Fen%2Fquote%2FNOU&amp;,%20esheet=54255452&amp;,%20newsitemid=20250515626279&amp;,%20lan=en-US&amp;,%20anchor=TSX%3A+NOU&amp;,%20index=3&amp;,%20TSX:%3Ca%20class=">NOU</a>) is advancing its Phase-2 commercial plans with progressing work on the project financing, engineering, procurement and construction preparation. The Company also files its <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnmg.com%2Fwp-content%2Fuploads%2F2025%2F05%2FNMG-2024-ESG-Report.pdf&amp;esheet=54255452&amp;newsitemid=20250515626279&amp;lan=en-US&amp;anchor=2024+ESG+Report&amp;index=4&amp;md5=1a85134dab09a1d58a4959d289f6824c">2024 ESG Report</a> that demonstrates continued stewardship of environmental, social and governance ("ESG") issues aligned with global decarbonization efforts and international standards as required by lenders, investors, and customers.
&nbsp;
Arne H Frandsen, Chair of NMG, said: "NMG is cleverly navigating the shifting global market, while steadfastly maintaining its ESG commitments. Our business model, rooted in the clean energy transition, strives to capitalize on Western economies' growing appetite for critical minerals, local and ESG-compliant supply chains, as well as reshoring manufacturing capacity. Our commercial agreements with Panasonic Energy and General Motors along with strong interest from strategic lenders and institutional investors strengthen our plans to develop a responsible and carbon-neutral source of active anode material, positioning NMG as a sustainable and innovative supplier for long-term growth."
Eric Desaulniers, Founder, President, and CEO of NMG, declared: "Consumer demand for electric vehicles ("EV") is undisputable and catalyzes the battery value chain, a strong driver for active anode material. Facing steep tariffs and tightening supplies, manufacturers are seeking alternatives to Chinese active anode material. NMG's ore-to-battery-material Phase-2 Matawinie Mine and Bécancour Battery Material Plant are timely set to enter market, offering simplified trade corridors, ESG compliance, reliability, and a scalable source."

NMG Advances Phase-2 Graphite Plans Amid Rising EV Demand and Feasibility Study Update

Edap TMS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDAP#NASDAQ">EDAP</a>) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.15) by 33.33 percent. This is a 53.85 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $14.28 million which missed the analyst consensus estimate of $14.90 million by 4.14 percent. This is a 11.45 percent decrease over sales of $16.13 million the same period last year.

EDAP

Edap TMS Q1 EPS $(0.20) Misses $(0.15) Estimate, Sales $14.28M Miss $14.90M Estimate

LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) reported quarterly losses of $(1.05) per share which missed the analyst consensus estimate of $(0.74) by 41.89 percent. This is a 272.13 percent decrease over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $2.37 million which missed the analyst consensus estimate of $2.85 million by 16.81 percent. This is a 50.06 percent decrease over sales of $4.75 million the same period last year.

LMFA

LM Funding America Q1 EPS $(1.05) Misses $(0.74) Estimate, Sales $2.37M Miss $2.85M Estimate

Voyager Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VYGR#NASDAQ">VYGR</a>), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced the first peer-reviewed publication of data demonstrating the ability of alkaline phosphatase (ALPL) to transport a novel AAV capsid across the blood-brain barrier (BBB). The article, titled "Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier," was published in Molecular Therapy and can be accessed <a href="https://www.globenewswire.com/Tracker?data=cj67Y-Knq303UIC-gtuXKW-aBxpe4WTcmnyda8PFmxVBLy2QEO7snPUifGEewxYoRNRUyW4tCr6zG09PKuYFg3wXavwAV_q1Erv4Kp6A4hhD-H_PtuyMkQkpb3Y2ZO-3cYvUz_bD-DghzrJopXu_-XMwqHwS3Jg2Z4V3Rk1WujE=">here</a>.

VYGR

Voyager Therapeutics Announces First Peer-Reviewed Publication Of Data Showing Ability Of Alkaline Phosphatase To Transport Novel AAV Capsid Across The Blood-brain Barrier

NVEE

Upon Closing Of The Transaction, Current Acuren Stockholders Will Own ~60%, And Current NV5 Stockholders Will Own ~40% Of The Combined Company

Walmart Q1 Revenue Of $165.6B Includes ~100 Bps Headwind From Lapping Leap Day

Tom Lee, co-founder and research head at&nbsp;Fundstrat Global Advisors, expressed optimism about the current market scenario, notwithstanding the recent volatility.
What Happened: Lee identified&nbsp;key indicators suggesting that the&nbsp;worst market decline may have passed and predicted a significant upside for stocks by 2026.&nbsp;On the Global Money Talk podcast on Tuesday, he emphasized that&nbsp;the recovery of 50% of&nbsp;the market&#8217;s losses, which took place the previous Friday, is a strong indication&nbsp;that the market may have&nbsp;reached its lowest point. 
He also observed that the high-yield bond market, a leading indicator for equities, has recovered 50% of its losses, further reinforcing the possibility of a stock market rebound. Lee advised investors to steer clear of decisions based on daily news cycles and instead concentrate on the potential for 2026 earnings to surpass expectations.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Markets Look Scary? Tom Lee Says $7 Trillion Is Ready to Buy &#x7C; Tom Lee, Fundstrat" width="500" height="281" src="https://www.youtube.com/embed/kCh2R5eEoL0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Despite the ongoing tariff war, Lee is confident that the U.S.&#8217;s&nbsp;potential for upside in exports,&nbsp;deregulation, and tax policy incentives could propel&nbsp;earnings growth and price-to-earnings (P/E)&nbsp;multiple expansion, creating a favorable&nbsp;environment for stocks.
Lee also mentioned that a trade-related recession is already in progress, but it is unlikely to instigate a full-blown U.S. recession unless paired with a significant shock. He dismissed the calls for a full-blown imminent recession and stated, &#8220;..for someone to be so confident that we're going to have a recession, I think they're dead wrong.&#8221; He also notes that many economists frequently struggle to accurately identify when recessions are actually occurring. &#8220;In my 30 years, I've never seen an economist get the recession right,&#8221; added Lee.
He keeps a close eye on&nbsp;the high-yield bond market, where&nbsp;spreads currently sit at 367 basis points—well&nbsp;below the 1,000 basis points&nbsp;that typically indicate an imminent recession. Lee also highlighted the $7 trillion in cash sitting on the sidelines.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45426516/chuck-schumer-says-trump-is-letting-cartel-members-into-the-us-asks-how-much-memecoin-did-" target="_blank" rel="noreferrer noopener">Chuck Schumer Says Trump Is &#8216;Letting Cartel Members&#8217; Into The US, Asks How Much &#8216;Memecoin&#8217; Did They Pay</a>
Why It Matters: Lee&#8217;s optimism comes after he previously <a href="https://www.benzinga.com/markets/25/04/44685594/tom-lee-predicts-a-v-shaped-recovery-for-us-stocks-pins-hope-on-trump-put-its-going-to-take-a-little-time">underestimated </a>the impact of tariffs on the market, which he likened to a &#8220;heart attack&#8221; for both the stock market and the broader economy. He predicted a V-shaped recovery and later urged Treasury Secretary Scott Bessent and Commerce Secretary Howard Lutnick to expedite trade deals for a positive &#8220;policy shock&#8221; to the stock markets.
Lee&#8217;s current outlook aligns with major brokerages such as Goldman Sachs, Barclays and J.P. Morgan, who have revised their U.S. recession forecasts <a href="https://www.benzinga.com/markets/25/05/45401678/goldman-sachs-barclays-jpm-walk-back-us-recession-forecasts-after-90-day-us-china-tariff-truce-fewer-fed-cuts-expected-in-2025">following </a>a 90-day tariff truce between the U.S. and China. Meanwhile, analysts like Jim Cramer believe that a &#8220;steady drip of trade deals&#8221; is essential for strengthening the market and easing recession concerns.
Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) soared more than 13%, while SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) surged 9.30% over the past month.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

Fundstrat's Tom Lee Says Economists Predicting A Recession With Certainty Are 'Dead Wrong': 'In My 30 Years, I've Never Seen...'

Needham analyst Serge Belanger maintains Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) with a Buy and lowers the price target from $4 to $3.

CLSD

Needham Maintains Buy on Clearside Biomedical, Lowers Price Target to $3

POAI

Predictive Oncology Q1 EPS $(0.34) Misses $(0.09) Estimate, Sales $110.00

Acuren And NV5 Announce Merger Agreement, Under Which NV5 Stockholders Will Receive $23/Share Consisting Of $10 In Cash And $12 In Acuren Shares For Total Consideration ~$1.7B; Deal Expected To Be Immediately Accretive To Acuren

Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) reported quarterly losses of $(0.14) per share. This is a 63.16 percent increase over losses of $(0.38) per share from the same period last year. The company reported $11.30 million in sales this quarter.

IVVD

Invivyd Q1 EPS $(0.14) Up From $(0.38) YoY, Sales $11.30M Up from 0 YoY

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="6">Second quarter</td>
<td colspan="3">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="6">The Company's second quarter fiscal 2026 guidance is based on Q2 FY25 net sales of $167.8 billion.</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">Consolidated metric</td>
<td colspan="3">Q2 FY26</td>
<td colspan="3">&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">Net sales (cc)</td>
<td colspan="3">
Increase 3.5% to 4.5%
•Including approximately 20 bps tailwind from acquisition of VIZIO
</td>
<td colspan="3">&nbsp;</td>
</tr>
</tbody>
</table>
</figure><figure class="table"> 
<table>
<tbody>
<tr>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td colspan="3">&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Walmart Sees Q2 Sales $173.673B-$175.350B vs $175.21B Est

Press Releases

FingerMotion Debuts Advanced Solutions for Nationwide Emergency Response Management

FingerMotion's Advanced Command and Communication (C2) Platform Awarded National Certification from China's Ministry of Industry and Information Technology

FingerMotion Reports Q2 2025 Financial Results

FingerMotion Announces $5.0 Million Registered Direct Offering

FingerMotion Announces Closing of $5.0 Million Registered Direct Offering

FingerMotion Reports Q3 2025 Financial Results

FingerMotion Awarded Multiple Contracts to Deliver Vehicles Equipped with Advanced Satellite Communication Command Platform

FingerMotion Announces Results of Annual Meeting

FingerMotion Announces Participation in the 37th Annual ROTH Conference

FingerMotion Announces Participation in the Skyline Signature Series Webinar

FNGR

America Movil, S.A.B. de C.V. American Depositary Shares (each representing the right to receive twenty (20) Series B Shares

America Movil

Gogo

Kore Group Holdings

PLDT

SK Telecom Co

Spok Holdings

Surgepays

Telephone and Data Systems, Inc. Common Shares

Telephone and Data Sys

Millicom International Cellular S.A. - Common Stock

Millicom Intl Cellular

TIM S.A. American Depositary Shares (Each representing 5 Common Shares)

Turkcell Iletisim Hizmetleri AS Common Stock

Turkcell Iletisim

T-Mobile US

uCloudlink Group Inc. - American Depositary Shares

Ucloudlink Group

United States Cellular Corporation Common Stock

United States Cellular

VEON

Vodafone Group Plc - American Depositary Shares each representing ten Ordinary Shares

Comments

FingerMotion

ニュース

最新ニュース FingerMotion (NASDAQ:FNGR) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル